Fabrinet (FN) Is Down 10.6% After Strong Q4 Beat And Upbeat 2027 Outlook Guidance - Has The Bull Case Changed?

Fabrinet

Fabrinet

FN

0.00

  • In the past quarter ended June 26, 2026, Fabrinet reported fourth-quarter sales of US$1.32 billion, net income of US$139.26 million, and diluted earnings per share from continuing operations of US$3.83, all higher than a year earlier.
  • The company also issued first-quarter 2027 guidance calling for revenue between US$1.38 billion and US$1.43 billion and GAAP net income per diluted share of US$3.39 to US$3.54, highlighting management’s confidence in current demand and its expanded manufacturing capacity.
  • We’ll now examine how Fabrinet’s strong year-over-year revenue and earnings growth may affect its existing investment narrative and risk profile.

The best AI stocks today may lie beyond giants like Nvidia and Microsoft. Find the next big opportunity with these 18 smaller AI-focused companies with strong growth potential through early-stage innovation in machine learning, automation, and data intelligence that could fund your retirement.

Fabrinet Investment Narrative Recap

To be a Fabrinet shareholder, you need to believe that demand for high‑speed optical and AI‑related hardware will keep supporting its manufacturing scale and engineering depth, while customer concentration and capacity investment risks remain manageable. The latest quarter’s higher sales and earnings, along with solid near term guidance, appear to support the key short term catalyst of strong hyperscale and datacom demand. These results do not meaningfully change the biggest immediate risk around dependence on a few large customers.

Among recent developments, the new Q1 FY2027 guidance for US$1.375 billion to US$1.425 billion in revenue and GAAP EPS of US$3.39 to US$3.54 stands out. It ties directly into the catalyst of continued AI and data center buildouts, suggesting Fabrinet expects its expanded capacity to remain well utilized in the near term. How well this demand holds up against customer concentration and potential supply constraints will be critical to watch.

Yet despite the strong headline numbers, investors should be aware that customer concentration could quickly become a problem if...

Fabrinet's narrative projects $8.0 billion revenue and $845.5 million earnings by 2029. This requires 23.8% yearly revenue growth and an earnings increase of roughly $424.5 million from $421.0 million today.

Uncover how Fabrinet's forecasts yield a $732.44 fair value, a 70% upside to its current price.

Exploring Other Perspectives

FN 1-Year Stock Price Chart
FN 1-Year Stock Price Chart

Some of the most optimistic analysts were already projecting around US$8.6 billion in revenue and US$910 million in earnings by 2029, which is far more bullish than consensus and assumes Fabrinet’s customer concentration risk will be outweighed by sustained optical demand, so this new quarter’s results could either reinforce or challenge that view depending on how you interpret the latest guidance.

Explore 9 other fair value estimates on Fabrinet - why the stock might be worth as much as 97% more than the current price!

The Verdict Is Yours

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

  • A great starting point for your Fabrinet research is our analysis highlighting 3 key rewards and 2 important warning signs that could impact your investment decision.
  • Our free Fabrinet research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Fabrinet's overall financial health at a glance.

Contemplating Other Strategies?

Our top stock finds are flying under the radar-for now. Get in early:

  • Find 49 companies with promising cash flow potential yet trading below their fair value.
  • This technology could replace computers: discover 24 stocks that are working to make quantum computing a reality.
  • We've uncovered the 12 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.